CoresteamChemo and ATG Lifetech Partner to Offer Advanced Preclinical CRO Services Worldwide

Korea’s CoresteamChemo & ATG Lifetech came Together to Expand the CRO’s Global Reach

Partnership Overview

A South Korea-based, leading GLP-certified preclinical CRO, CoresteamChemo, and a biotechnology company specialized in transcriptome analytics and organoid-based modeling, ATG Lifetech, came into strategic collaborations to offer next-generation and precision-based non-clinical solutions to pharmaceutical and biotech companies in regions like the U.S., Europe, and Asia. Both companies will demonstrate their joint research efforts at a major toxicology and preclinical science conference, which will be held in Q4 2025. Companies will also launch multiple global services for biotech and pharmaceutical customers that require high-content and biologically trusted preclinical testing.

With this collaboration, CoresteamChemo and ATG Lifetech are planning to co-develop several initiatives, including:

• A transcriptomic-based evaluation platform, designed to predict drug efficacy and safety profiling of disease-significant organoid models for the heart, liver, and blood-brain barrier.
• A highly efficient transcriptomics analytical service to differentiate true vs. false positives in tumorigenesis studies.
• Both companies will share their access for regulatory coordinated experiences in global clients to target FDA/EMA pathways.

Organoid-based assays are known for their translational benefits and provide about 5x greater predictive accuracy. This assay is highly used in toxicity and efficacy screening for greater predictive accuracy than traditional 2D cell culture.

About CoresteamChemo

The CoresteamChemo is a full-service preclinical CRO with experience of more than two decades in GLP-based toxicology, pharmacokinetics, and regulatory compliance. Several AAALAC-certified facilities and partners with pharmaceutical innovators across the region of U.S., Europe, and Asia operate througt the CoresteamChemo.

About ATG Lifetech

ATG Lifetech is well-known for driving validated experiences like ACROBiosystems from its international collaborations. The company has received its selection or core development in various South Korean government-supported biopharma initiatives.

Major Statement

A CoresteamChemo spokesperson made the statement that, “the disruptive transcriptome and organoid platforms of ATG Lifetech are expected to elevate the scientific fidelity to CoresteamChemo’s preclinical services significantly. This partnership will enable the company to compete as a global CRO partner that provides best-in-class biological applications and regulatory readiness.